HEADER OXIDOREDUCTASE 30-NOV-99 1DIY TITLE CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE TITLE 2 ACTIVE SITE OF PGHS-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROSTAGLANDIN H2 SYNTHASE-1; COMPND 3 CHAIN: A; COMPND 4 EC: 1.14.99.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: OVIS ARIES; SOURCE 3 ORGANISM_COMMON: SHEEP; SOURCE 4 ORGANISM_TAXID: 9940; SOURCE 5 ORGAN: SEMINAL VESSICLE KEYWDS ARACHIDONIC ACID, MEMBRANE PROTEIN, PEROXIDASE, DIOXYGENASE, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.G.MALKOWSKI,S.L.GINELL,W.L.SMITH,R.M.GARAVITO REVDAT 7 30-OCT-24 1DIY 1 REMARK REVDAT 6 09-AUG-23 1DIY 1 HETSYN REVDAT 5 29-JUL-20 1DIY 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 30-MAY-18 1DIY 1 REMARK REVDAT 3 13-JUL-11 1DIY 1 VERSN REVDAT 2 24-FEB-09 1DIY 1 VERSN REVDAT 1 22-SEP-00 1DIY 0 JRNL AUTH M.G.MALKOWSKI,S.L.GINELL,W.L.SMITH,R.M.GARAVITO JRNL TITL THE PRODUCTIVE CONFORMATION OF ARACHIDONIC ACID BOUND TO JRNL TITL 2 PROSTAGLANDIN SYNTHASE. JRNL REF SCIENCE V. 289 1933 2000 JRNL REFN ISSN 0036-8075 JRNL PMID 10988074 JRNL DOI 10.1126/SCIENCE.289.5486.1933 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 18519 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 5% OF THE TOTAL REFLECTIONS REMARK 3 WERE SELECTED BY CNS USING REMARK 3 THE SCRIPT MAKE_CV.INP REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 880 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1468 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE : 0.4150 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 72 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4409 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 262 REMARK 3 SOLVENT ATOMS : 109 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.54 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.50 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.69 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.510 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.96 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.040 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 USED THE MLF TARGET IN CNS UTILIZING BULK SOLVENT AND OVERALL B- REMARK 3 FACTOR REMARK 3 CORRECTIONS REMARK 4 REMARK 4 1DIY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-DEC-99. REMARK 100 THE DEPOSITION ID IS D_1000010117. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03321 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19163 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 9.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1PRH MOLECULE B, PROTEIN ONLY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LITHIUM CHLORIDE, SODIUM AZIDE, SODIUM REMARK 280 CITRATE, N-OCTYL GLUCOSIDE, PH 6.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.09333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.54667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 51.82000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 17.27333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 86.36667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.09333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 34.54667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 17.27333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 51.82000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 86.36667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 273.15000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 -157.70323 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -34.54667 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 83 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 169 CG CD CE NZ REMARK 470 GLN A 170 CG CD OE1 NE2 REMARK 470 ASP A 173 CG OD1 OD2 REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 LYS A 186 CG CD CE NZ REMARK 470 LYS A 215 CG CD CE NZ REMARK 470 LYS A 248 CG CD CE NZ REMARK 470 GLU A 267 CG CD OE1 OE2 REMARK 470 GLU A 290 CG CD OE1 OE2 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 ARG A 396 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 400 CG CD OE1 NE2 REMARK 470 GLU A 405 CG CD OE1 OE2 REMARK 470 ASP A 416 CG OD1 OD2 REMARK 470 LYS A 473 CG CD CE NZ REMARK 470 GLN A 479 CG CD OE1 NE2 REMARK 470 LYS A 485 CG CD CE NZ REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 34 100.27 -48.41 REMARK 500 CYS A 36 3.36 -58.62 REMARK 500 CYS A 59 3.23 -63.40 REMARK 500 THR A 60 129.81 -38.53 REMARK 500 ARG A 61 27.63 48.94 REMARK 500 CYS A 69 61.33 63.40 REMARK 500 HIS A 95 -52.82 -139.64 REMARK 500 ARG A 97 27.54 -55.86 REMARK 500 TRP A 98 -50.41 -137.76 REMARK 500 ALA A 105 33.75 -95.52 REMARK 500 LEU A 117 -79.78 -47.51 REMARK 500 THR A 118 -74.04 -29.78 REMARK 500 THR A 129 -96.75 -102.25 REMARK 500 ASP A 135 41.99 -98.05 REMARK 500 VAL A 145 -11.90 -48.42 REMARK 500 PRO A 153 -171.78 -61.81 REMARK 500 ARG A 157 18.45 -66.59 REMARK 500 PRO A 160 -77.55 -41.06 REMARK 500 LYS A 169 -6.21 -56.78 REMARK 500 ARG A 185 -77.19 -101.27 REMARK 500 THR A 194 150.23 -46.76 REMARK 500 ALA A 223 83.81 -65.74 REMARK 500 HIS A 226 62.28 38.87 REMARK 500 ILE A 233 -56.42 -124.25 REMARK 500 PHE A 247 55.15 14.10 REMARK 500 GLU A 268 -36.10 147.19 REMARK 500 ALA A 269 65.87 -113.80 REMARK 500 PRO A 270 58.00 -58.29 REMARK 500 MET A 273 -148.74 -128.64 REMARK 500 HIS A 274 15.52 -155.50 REMARK 500 ARG A 277 97.93 -53.89 REMARK 500 PRO A 280 2.57 -58.20 REMARK 500 PRO A 281 -91.43 -92.58 REMARK 500 SER A 283 15.13 58.38 REMARK 500 GLN A 284 77.20 -117.51 REMARK 500 VAL A 287 -46.07 -134.83 REMARK 500 GLU A 290 -42.87 -25.34 REMARK 500 THR A 322 19.99 -62.77 REMARK 500 GLN A 327 -71.89 -55.47 REMARK 500 PHE A 329 -70.58 -64.34 REMARK 500 GLU A 347 -46.89 -137.02 REMARK 500 GLN A 350 -71.19 -60.74 REMARK 500 LEU A 359 146.80 -38.50 REMARK 500 ARG A 374 125.49 -174.02 REMARK 500 ARG A 376 103.33 -162.09 REMARK 500 TRP A 387 51.07 -90.64 REMARK 500 PRO A 392 -162.15 -71.87 REMARK 500 TYR A 402 155.08 -45.14 REMARK 500 PHE A 409 -2.50 50.22 REMARK 500 ASN A 410 160.87 -48.67 REMARK 500 REMARK 500 THIS ENTRY HAS 62 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 823 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A 842 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH A 844 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH A 848 DISTANCE = 6.13 ANGSTROMS REMARK 525 HOH A 861 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A 875 DISTANCE = 7.21 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 COH A 601 CO REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 388 NE2 REMARK 620 2 COH A 601 NA 106.8 REMARK 620 3 COH A 601 NB 88.8 86.0 REMARK 620 4 COH A 601 NC 73.3 178.9 92.9 REMARK 620 5 COH A 601 ND 91.8 95.9 177.8 85.3 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CVU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE REMARK 900 ACTIVE SITE OF COX-2 REMARK 900 RELATED ID: 1DDX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A MIXTURE OF ARACHIDONIC ACID AND REMARK 900 PROSTAGLANDIN BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2: REMARK 900 PROSTAGLANDIN STRUCTURE REMARK 900 RELATED ID: 1PRH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MEMBRANE PROTEIN PROSTAGLANDIN H2 SYNTHASE- REMARK 900 1 REMARK 900 RELATED ID: 1PTH RELATED DB: PDB REMARK 900 THE STRUCTURAL BASIS OF ASPIRIN ACTIVITY INFERRED FROM THE CRYSTAL REMARK 900 STRUCTURE OF INACTIVATED PROSTAGLANDIN H2 SYNTHASE-1 REMARK 900 RELATED ID: 1PGE RELATED DB: PDB REMARK 900 SYNTHESIS AND USE OF IODINATED NONSTEROIDAL ANTIINFLAMMATORY DRUG REMARK 900 ANALOGS AS CRYSTALLOGRAPHIC PROBES OF THE PROSTAGLANDIN H2 SYNTHASE- REMARK 900 1 CYCLOOXYGENASE ACTIVE SITE DBREF 1DIY A 32 584 GB 165844 AAA31511 31 583 SEQRES 1 A 553 PRO VAL ASN PRO CYS CYS TYR TYR PRO CYS GLN HIS GLN SEQRES 2 A 553 GLY ILE CYS VAL ARG PHE GLY LEU ASP ARG TYR GLN CYS SEQRES 3 A 553 ASP CYS THR ARG THR GLY TYR SER GLY PRO ASN CYS THR SEQRES 4 A 553 ILE PRO GLU ILE TRP THR TRP LEU ARG THR THR LEU ARG SEQRES 5 A 553 PRO SER PRO SER PHE ILE HIS PHE LEU LEU THR HIS GLY SEQRES 6 A 553 ARG TRP LEU TRP ASP PHE VAL ASN ALA THR PHE ILE ARG SEQRES 7 A 553 ASP THR LEU MET ARG LEU VAL LEU THR VAL ARG SER ASN SEQRES 8 A 553 LEU ILE PRO SER PRO PRO THR TYR ASN ILE ALA HIS ASP SEQRES 9 A 553 TYR ILE SER TRP GLU SER PHE SER ASN VAL SER TYR TYR SEQRES 10 A 553 THR ARG ILE LEU PRO SER VAL PRO ARG ASP CYS PRO THR SEQRES 11 A 553 PRO MET GLY THR LYS GLY LYS LYS GLN LEU PRO ASP ALA SEQRES 12 A 553 GLU PHE LEU SER ARG ARG PHE LEU LEU ARG ARG LYS PHE SEQRES 13 A 553 ILE PRO ASP PRO GLN GLY THR ASN LEU MET PHE ALA PHE SEQRES 14 A 553 PHE ALA GLN HIS PHE THR HIS GLN PHE PHE LYS THR SER SEQRES 15 A 553 GLY LYS MET GLY PRO GLY PHE THR LYS ALA LEU GLY HIS SEQRES 16 A 553 GLY VAL ASP LEU GLY HIS ILE TYR GLY ASP ASN LEU GLU SEQRES 17 A 553 ARG GLN TYR GLN LEU ARG LEU PHE LYS ASP GLY LYS LEU SEQRES 18 A 553 LYS TYR GLN MET LEU ASN GLY GLU VAL TYR PRO PRO SER SEQRES 19 A 553 VAL GLU GLU ALA PRO VAL LEU MET HIS TYR PRO ARG GLY SEQRES 20 A 553 ILE PRO PRO GLN SER GLN MET ALA VAL GLY GLN GLU VAL SEQRES 21 A 553 PHE GLY LEU LEU PRO GLY LEU MET LEU TYR ALA THR ILE SEQRES 22 A 553 TRP LEU ARG GLU HIS ASN ARG VAL CYS ASP LEU LEU LYS SEQRES 23 A 553 ALA GLU HIS PRO THR TRP GLY ASP GLU GLN LEU PHE GLN SEQRES 24 A 553 THR ALA ARG LEU ILE LEU ILE GLY GLU THR ILE LYS ILE SEQRES 25 A 553 VAL ILE GLU GLU TYR VAL GLN GLN LEU SER GLY TYR PHE SEQRES 26 A 553 LEU GLN LEU LYS PHE ASP PRO GLU LEU LEU PHE GLY ALA SEQRES 27 A 553 GLN PHE GLN TYR ARG ASN ARG ILE ALA MET GLU PHE ASN SEQRES 28 A 553 GLN LEU TYR HIS TRP HIS PRO LEU MET PRO ASP SER PHE SEQRES 29 A 553 ARG VAL GLY PRO GLN ASP TYR SER TYR GLU GLN PHE LEU SEQRES 30 A 553 PHE ASN THR SER MET LEU VAL ASP TYR GLY VAL GLU ALA SEQRES 31 A 553 LEU VAL ASP ALA PHE SER ARG GLN PRO ALA GLY ARG ILE SEQRES 32 A 553 GLY GLY GLY ARG ASN ILE ASP HIS HIS ILE LEU HIS VAL SEQRES 33 A 553 ALA VAL ASP VAL ILE LYS GLU SER ARG VAL LEU ARG LEU SEQRES 34 A 553 GLN PRO PHE ASN GLU TYR ARG LYS ARG PHE GLY MET LYS SEQRES 35 A 553 PRO TYR THR SER PHE GLN GLU LEU THR GLY GLU LYS GLU SEQRES 36 A 553 MET ALA ALA GLU LEU GLU GLU LEU TYR GLY ASP ILE ASP SEQRES 37 A 553 ALA LEU GLU PHE TYR PRO GLY LEU LEU LEU GLU LYS CYS SEQRES 38 A 553 HIS PRO ASN SER ILE PHE GLY GLU SER MET ILE GLU MET SEQRES 39 A 553 GLY ALA PRO PHE SER LEU LYS GLY LEU LEU GLY ASN PRO SEQRES 40 A 553 ILE CYS SER PRO GLU TYR TRP LYS ALA SER THR PHE GLY SEQRES 41 A 553 GLY GLU VAL GLY PHE ASN LEU VAL LYS THR ALA THR LEU SEQRES 42 A 553 LYS LYS LEU VAL CYS LEU ASN THR LYS THR CYS PRO TYR SEQRES 43 A 553 VAL SER PHE HIS VAL PRO ASP MODRES 1DIY ASN A 68 ASN GLYCOSYLATION SITE MODRES 1DIY ASN A 144 ASN GLYCOSYLATION SITE MODRES 1DIY ASN A 410 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NDG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET BMA C 4 11 HET MAN C 5 11 HET NAG D 1 14 HET NAG D 2 14 HET BOG A 750 20 HET BOG A 751 20 HET BOG A 752 20 HET BOG A 753 20 HET COH A 601 43 HET ACD A 700 22 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM COH PROTOPORPHYRIN IX CONTAINING CO HETNAM ACD ARACHIDONIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 NAG 5(C8 H15 N O6) FORMUL 2 NDG C8 H15 N O6 FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN C6 H12 O6 FORMUL 5 BOG 4(C14 H28 O6) FORMUL 9 COH C34 H32 CO N4 O4 FORMUL 10 ACD C20 H32 O2 FORMUL 11 HOH *109(H2 O) HELIX 1 1 ASN A 34 TYR A 38 5 5 HELIX 2 2 GLU A 73 ARG A 83 1 11 HELIX 3 3 SER A 85 THR A 94 1 10 HELIX 4 4 TRP A 98 ALA A 105 1 8 HELIX 5 5 PHE A 107 ASN A 122 1 16 HELIX 6 6 SER A 138 ASN A 144 1 7 HELIX 7 7 ASP A 173 LEU A 182 1 10 HELIX 8 8 ASN A 195 HIS A 207 1 13 HELIX 9 9 ASN A 237 ARG A 245 1 9 HELIX 10 10 LEU A 295 HIS A 320 1 26 HELIX 11 11 GLY A 324 GLU A 347 1 24 HELIX 12 12 GLU A 347 GLY A 354 1 8 HELIX 13 13 ASP A 362 PHE A 367 5 6 HELIX 14 14 ALA A 378 TYR A 385 1 8 HELIX 15 15 HIS A 386 HIS A 386 5 1 HELIX 16 16 TRP A 387 MET A 391 5 5 HELIX 17 17 SER A 403 LEU A 408 1 6 HELIX 18 18 SER A 412 GLY A 418 1 7 HELIX 19 19 GLY A 418 GLN A 429 1 12 HELIX 20 20 ILE A 444 ARG A 459 1 16 HELIX 21 21 PRO A 462 PHE A 470 1 9 HELIX 22 22 SER A 477 THR A 482 1 6 HELIX 23 23 LYS A 485 GLY A 496 1 12 HELIX 24 24 ASP A 497 LEU A 501 5 5 HELIX 25 25 GLU A 502 GLU A 510 1 9 HELIX 26 26 GLY A 519 GLY A 536 1 18 HELIX 27 27 ASN A 537 SER A 541 5 5 HELIX 28 28 LYS A 546 PHE A 550 5 5 HELIX 29 29 GLY A 552 THR A 561 1 10 HELIX 30 30 THR A 563 LEU A 570 1 8 SHEET 1 A 2 ILE A 46 PHE A 50 0 SHEET 2 A 2 ARG A 54 ASP A 58 -1 O ARG A 54 N PHE A 50 SHEET 1 B 2 TYR A 64 SER A 65 0 SHEET 2 B 2 ILE A 71 PRO A 72 -1 N ILE A 71 O SER A 65 SHEET 1 C 2 GLN A 255 LEU A 257 0 SHEET 2 C 2 GLU A 260 TYR A 262 -1 O GLU A 260 N LEU A 257 SHEET 1 D 2 PHE A 395 VAL A 397 0 SHEET 2 D 2 GLN A 400 TYR A 402 -1 O GLN A 400 N VAL A 397 SSBOND 1 CYS A 36 CYS A 47 1555 1555 2.05 SSBOND 2 CYS A 37 CYS A 159 1555 1555 2.04 SSBOND 3 CYS A 41 CYS A 57 1555 1555 2.03 SSBOND 4 CYS A 59 CYS A 69 1555 1555 2.03 SSBOND 5 CYS A 569 CYS A 575 1555 1555 2.03 LINK ND2 ASN A 68 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 144 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN A 410 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NDG B 2 1555 1555 1.41 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.40 LINK O6 BMA C 3 C1 BMA C 4 1555 1555 1.41 LINK O3 BMA C 4 C1 MAN C 5 1555 1555 1.41 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK NE2 HIS A 388 CO COH A 601 1555 1555 2.16 CISPEP 1 SER A 126 PRO A 127 0 0.19 CRYST1 182.100 182.100 103.640 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005491 0.003171 0.000000 0.00000 SCALE2 0.000000 0.006341 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009649 0.00000